We also compared the clinical features of obese carriers and noncarriers of the missense variant and found no substantial difference between the two groups in parameters related to metabolic disorders, including obesity traits, blood glucose, insulin sensitivity, islet β cell function, serum lipids, and liver enzymes (Supplementary Table S4). The gene discussed is INS; the disease is metabolic disease.